Insider trade

Anixa Biosciences (ANIX): Director bought ~$31K

Lewis H jr Titterton, Director at Anixa Biosciences, bought ~$31K of Anixa Biosciences shares.

~$31K
Approx. value · 10K sh @ $3.08: 953K
Holds after · shares reported

Traded: Jul 31, 2025
Filed: Aug 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jun 4, 2025InsiderCEO purchased ~$29K of ANIX shares in the open market
Jul 11, 2025Insider · 2 peopleInsiders: 2 purchases (~$47K)
Jul 18, 2025InsiderDirector purchased ~$17K of ANIX shares in the open market
Jul 30, 2025InsiderCEO purchased ~$16K of ANIX shares in the open market
Jul 31, 2025 · this disclosureInsiderDirector purchased ~$31K of ANIX shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Anixa Biosciences

For Anixa Biosciences, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANIX page.

Other recent filings by Lewis H jr Titterton, Director

The full history of Lewis H jr Titterton, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Anixa Biosciences

Everything OQRO holds on this company is on its ANIX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data